Cargando…
Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005)
Following the submission of application EFSA‐GMO‐RX‐005 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010151/ https://www.ncbi.nlm.nih.gov/pubmed/32625301 http://dx.doi.org/10.2903/j.efsa.2017.5006 |
_version_ | 1783495824365322240 |
---|---|
author | Naegeli, Hanspeter Birch, Andrew Nicholas Casacuberta, Josep De Schrijver, Adinda Gralak, Mikołaj Antoni Guerche, Philippe Jones, Huw Manachini, Barbara Messéan, Antoine Nielsen, Elsa Ebbesen Nogué, Fabien Robaglia, Christophe Rostoks, Nils Sweet, Jeremy Tebbe, Christoph Visioli, Francesco Wal, Jean‐Michel Álvarez, Fernando Ardizzone, Michele Papadopoulou, Nikoletta |
author_facet | Naegeli, Hanspeter Birch, Andrew Nicholas Casacuberta, Josep De Schrijver, Adinda Gralak, Mikołaj Antoni Guerche, Philippe Jones, Huw Manachini, Barbara Messéan, Antoine Nielsen, Elsa Ebbesen Nogué, Fabien Robaglia, Christophe Rostoks, Nils Sweet, Jeremy Tebbe, Christoph Visioli, Francesco Wal, Jean‐Michel Álvarez, Fernando Ardizzone, Michele Papadopoulou, Nikoletta |
collection | PubMed |
description | Following the submission of application EFSA‐GMO‐RX‐005 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide‐tolerant genetically modified maize GA21. The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatics analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in maize GA21 considered for renewal is identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in the renewal application EFSA‐GMO‐RX‐005 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize GA21. |
format | Online Article Text |
id | pubmed-7010151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70101512020-07-02 Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) Naegeli, Hanspeter Birch, Andrew Nicholas Casacuberta, Josep De Schrijver, Adinda Gralak, Mikołaj Antoni Guerche, Philippe Jones, Huw Manachini, Barbara Messéan, Antoine Nielsen, Elsa Ebbesen Nogué, Fabien Robaglia, Christophe Rostoks, Nils Sweet, Jeremy Tebbe, Christoph Visioli, Francesco Wal, Jean‐Michel Álvarez, Fernando Ardizzone, Michele Papadopoulou, Nikoletta EFSA J Scientific Opinion Following the submission of application EFSA‐GMO‐RX‐005 under Regulation (EC) No 1829/2003 from Syngenta Crop Protection NV/SA, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide‐tolerant genetically modified maize GA21. The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatics analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in maize GA21 considered for renewal is identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in the renewal application EFSA‐GMO‐RX‐005 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize GA21. John Wiley and Sons Inc. 2017-10-24 /pmc/articles/PMC7010151/ /pubmed/32625301 http://dx.doi.org/10.2903/j.efsa.2017.5006 Text en © 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Scientific Opinion Naegeli, Hanspeter Birch, Andrew Nicholas Casacuberta, Josep De Schrijver, Adinda Gralak, Mikołaj Antoni Guerche, Philippe Jones, Huw Manachini, Barbara Messéan, Antoine Nielsen, Elsa Ebbesen Nogué, Fabien Robaglia, Christophe Rostoks, Nils Sweet, Jeremy Tebbe, Christoph Visioli, Francesco Wal, Jean‐Michel Álvarez, Fernando Ardizzone, Michele Papadopoulou, Nikoletta Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title | Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title_full | Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title_fullStr | Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title_full_unstemmed | Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title_short | Assessment of genetically modified maize GA21 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐005) |
title_sort | assessment of genetically modified maize ga21 for renewal of authorisation under regulation (ec) no 1829/2003 (application efsa‐gmo‐rx‐005) |
topic | Scientific Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7010151/ https://www.ncbi.nlm.nih.gov/pubmed/32625301 http://dx.doi.org/10.2903/j.efsa.2017.5006 |
work_keys_str_mv | AT assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT naegelihanspeter assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT birchandrewnicholas assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT casacubertajosep assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT deschrijveradinda assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT gralakmikołajantoni assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT guerchephilippe assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT joneshuw assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT manachinibarbara assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT messeanantoine assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT nielsenelsaebbesen assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT noguefabien assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT robagliachristophe assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT rostoksnils assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT sweetjeremy assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT tebbechristoph assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT visiolifrancesco assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT waljeanmichel assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT alvarezfernando assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT ardizzonemichele assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 AT papadopoulounikoletta assessmentofgeneticallymodifiedmaizega21forrenewalofauthorisationunderregulationecno18292003applicationefsagmorx005 |